Therapy of lower respiratory tract infections with moxalactam.
Moxalactam was evaluated in the therapy of lower respiratory tract infections in 40 patients. The most common organisms isolated were Streptococcus pneumoniae (37.2%) and Haemophilus influenzae (21.5%). Gram-negative enteric organisms were isolated from six patients. No patient was evaluated as a tr...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1981
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181526/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6457557/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.19.5.801 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|